Global Conference 2010
Program Leader, Neglected Diseases, Anacor Pharmaceuticals Inc.
Eric Easom is the Program Leader for the Neglected Diseases Initiative at Anacor Pharmaceuticals Inc., overseeing the company's licensing and research and development efforts to advance new therapeutics for the treatment of neglected diseases. Easom has spent a number of years actively working with not-for-profits focused on identifying ways to reduce the burden of neglected diseases worldwide, and he currently serves as chairman of the Infectious Disease Research Institute. Easom brings more than 19 years of pharmaceutical and biotech experience from various leadership roles in marketing, business development, R&D program and alliance management, finance and manufacturing from his time at Eli Lilly and Company, MedImmune, McKesson and InteKrin Therapeutics. He received an M.B.A. from Indiana University and a B.S. and master's degree in engineering from the University of Louisville.